Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Trevena Inc
TRVN
Healthcare
Biotechnology
Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of medicines for patients with central nervous system (CNS) disorders. The Company has one approved product in the United States, OLINVYK (oliceridine) injection, indicated in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative...
treatments are inadequate. The Company’s pipeline includes three differentiated investigational drug candidates: TRV045 for diabetic neuropathic pain and epilepsy, TRV250 for the acute treatment of migraine and TRV734 for maintenance treatment of opioid use disorder. TRV045 is a novel, highly selective sphingosine-1-phosphate subtype 1 (S1P1) receptor modulator being developed as a potential treatment for acute and chronic neuropathic pain secondary to diabetic peripheral neuropathy. TRV734 is a small molecule G-protein biased ligand of the mu opioid receptor (MOR).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCPK:TRVN)
New Post
View:
Posts & Comments
Threaded Posts
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jun 20, 2024 8:47am
TRVN.....get ready for the opening bell dumpfest ; )
Cheers !
(110)
•••
GolongGekko
X
View Profile
View Bullboard History
Comment by
GolongGekko
on Oct 07, 2020 11:30pm
RE:RE:BANGARAG - OLI is FDA APPROVED!!!!!
TRVN must be HOT...The WEASEL is back WHACKIN'it!! Best GG
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 23, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(10)
•••
ferret_ca
X
View Profile
View Bullboard History
Comment by
ferret_ca
on Sep 25, 2020 5:08pm
RE:BANGARAG - OLI is FDA APPROVED!!!!!
Hey Gekko, you still livin in yer mom's basement , lol, how ya been, happy to see your trvn finally do something for ya, cheers ferret
(13)
•••
SandMan67
X
View Profile
View Bullboard History
Post by
SandMan67
on Aug 08, 2020 5:38am
FDA site
On FDA site as well as 'popular news' sites. Trevena will do a press release Monday (hopefully before open) and the stock should respond for a nice gain. They will also publish
...more
(110)
•••
GolongGekko
X
View Profile
View Bullboard History
Post by
GolongGekko
on Aug 07, 2020 8:26pm
BANGARAG - OLI is FDA APPROVED!!!!!
https://apnews.com/PR%20Newswire/9e564a43c97adf428b4d5a70478465b5 It PAYS to be A GEKKO . . . Only took 3+ years! Best to all my Minions! GG
(13)
•••
SandMan67
X
View Profile
View Bullboard History
Post by
SandMan67
on Aug 06, 2020 1:57pm
FDA - Oliceridine
One more day and we find out if the FDA has approved their resubmission on their morphine alternative drug. https://www.globenewswire.com/news-release/2020/03/05/1995745/0/en/Trevena
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >